Skip to main content

Table 3 Factors influencing the prevalence of anaemia in the study population

From: Malaria infection and anaemia in HIV-infected children in Mutengene, Southwest Cameroon: a cross sectional study

Characteristic/category Number examined Number anaemic (%) Bivariate analysis Multivariate analysis
OR (95 % CI) p-value$ OR (95 % CI) p-value£
Age group (years)
  < 5 66 22 (33.3) 0.36 (0.17–0.77) 0.014* 0.68 (0.25–1.87) 0.45
 5–10 120 66 (55.0) 0.87 (0.44–1.72) 0.825 0.74 (0.34–1.62) 0.45
 11–15 48 28 (58.3) Reference    
Sex
 Female 138 74 (53.6) 1.49 (0.88–2.51) 0.176 2.15 (1.11–4.15) 0.024*
 Male 96 42 (43.7) Reference    
Presence of fever
 No 220 104 (47.3) Reference    
 Yes 14 12 (85.7) 6.69 (1.46–30.60) 0.012* 3.65 (0.69–19.20) 0.13
CD4 T Cell category (cells/μl)
  < 200 28 16 (57.1) 2.10 (0.92–4.76) 0.114 1.99 (0.76–5.18) 0.16
 200–499 44 32 (72.7) 4.19 (1.99–8.81) 0.00017* 3.79 (1.68–8.52) 0.0013*
  ≥ 500 144 56 (38.9) Reference    
Clinical stages
 Stage 1 44 18 (40.9) 0.48 (0.12–1.20) 0.180 0.73 (0.24–2.17) 0.57
 Stage 2 62 34 (54.8) 0.85 (0.36–1.98) 0.87 0.97 (0.35–2.64) 0.95
 Stage 3 82 36 (43.9) 0.55 (0.24–1.23) 0.21 0.45 (0.18–1.15) 0.09
 Stage 4 34 20 (58.8) Reference    
Use of ART
 No 52 30 (57.7) 1.52 (0.82–2.84) 0.242 1.29 (0.60–1.29) 0.51
 Yes 182 86 (47.3) Reference    
  1. OR Odds Ratio, CI Confidence Interval, $: Estimated by Yates adjusted Chi-Square, £: Estimated by Multiple Logistic Regression. *Statistically significant